Inmune Bio Inc (INMB)

Nov 13, 2024

INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease - The Manila Times

Nov 13, 2024

Nov 13, 2024

Inmune Bio Emerges as Biotech Innovator in 2023 - TipRanks

Nov 13, 2024

Nov 08, 2024

Learn to Evaluate (INMB) using the Charts - Stock Traders Daily

Nov 08, 2024

Nov 05, 2024

INmune Bio, Inc. (NASDAQ:INMB) Q3 2024 Earnings Call Transcript - MSN

Nov 05, 2024

Nov 03, 2024

INmune Bio (NASDAQ:INMB) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPS - MarketBeat

Nov 03, 2024

Nov 03, 2024

Is INmune Bio (NASDAQ:INMB) Using Debt In A Risky Way? - Simply Wall St

Nov 03, 2024

Nov 03, 2024

INmune Bio Third Quarter 2024 Earnings: US$0.60 loss per share (vs US$0.48 loss in 3Q 2023) - Yahoo Finance UK

Nov 03, 2024

Nov 01, 2024

INmune Bio Inc (INMB) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges and ... - Yahoo Finance

Nov 01, 2024

Nov 01, 2024

Earnings call: INmune Bio Q3 2024 results show progress in clinical trials - Investing.com

Nov 01, 2024

Nov 01, 2024

Inmune Bio Reports Increased Losses Amid Financing Efforts - TipRanks

Nov 01, 2024

Oct 31, 2024

INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update - The Manila Times

Oct 31, 2024

Oct 31, 2024

INmune Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Oct 31, 2024

Oct 31, 2024

INmune Bio Q3 2024 Earnings Preview - MSN

Oct 31, 2024

Oct 31, 2024

Short Interest in INmune Bio, Inc. (NASDAQ:INMB) Increases By 5.6% - MarketBeat

Oct 31, 2024

Oct 30, 2024

INmune Bio Inc (INMB) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance

Oct 30, 2024

Oct 28, 2024

INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB - The Manila Times

Oct 28, 2024

Oct 25, 2024

Highbridge Capital Management's Strategic Acquisition of INmune Bio Inc Shares - Yahoo Finance

Oct 25, 2024

Oct 25, 2024

INmune Bio (INMB) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat

Oct 25, 2024

Oct 24, 2024

INmune Bio Says XPro1595 Promotes Remyelination, Key for Central Nervous System Diseases - MarketWatch

Oct 24, 2024

Oct 24, 2024

INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination - The Manila Times

Oct 24, 2024

Oct 24, 2024

INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024 - The Manila Times

Oct 24, 2024

Oct 24, 2024

Insider Stock Buying Reaches US$951.2k On INmune Bio - Yahoo Finance

Oct 24, 2024

Oct 21, 2024

Alliance Global Partners Begins Coverage on INmune Bio (NASDAQ:INMB) - MarketBeat

Oct 21, 2024

Oct 20, 2024

Reviewing Windtree Therapeutics (NASDAQ:WINT) and INmune Bio (NASDAQ:INMB) - Defense World

Oct 20, 2024

Oct 18, 2024

(INMB) Technical Data - Stock Traders Daily

Oct 18, 2024

Oct 15, 2024

INmune Bio stock hits 52-week low at $4.8 amid market challenges - Investing.com

Oct 15, 2024

Oct 14, 2024

INmune Bio, Inc. (NASDAQ:INMB) Sees Large Decrease in Short Interest - MarketBeat

Oct 14, 2024

Oct 11, 2024

INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit - The Manila Times

Oct 11, 2024

Oct 09, 2024

INmune Bio Inc (INMB) Q2 2024 Earnings Call Highlights: Promising Advances Amid Rising Costs By GuruFocus - Investing.com Canada

Oct 09, 2024

Oct 09, 2024

INmune Bio Inc (INMB) Q2 2024 Earnings Call Highlights: Promising Advances Amid Rising Costs - Yahoo Finance

Oct 09, 2024

Oct 07, 2024

Where are the Opportunities in (INMB) - Stock Traders Daily

Oct 07, 2024

Sep 30, 2024

Insider Buying: CFO and 10% Owner David Moss Acquires Shares of INmune Bio Inc (INMB) - GuruFocus.com

Sep 30, 2024

Sep 30, 2024

INmune Bio, Inc. (NASDAQ:INMB) CFO David J. Moss Buys 10,000 Shares - Defense World

Sep 30, 2024

Sep 30, 2024

Inmune Bio CFO buys $52,868 in company stock - Investing.com India

Sep 30, 2024

Sep 30, 2024

Inmune Bio CFO buys $52,868 in company stock By Investing.com - Investing.com South Africa

Sep 30, 2024

Sep 30, 2024

Analytical Overview: INmune Bio Inc (INMB)’s Ratios Tell a Financial Story - The Dwinnex

Sep 30, 2024

Sep 30, 2024

INmune Bio Inc [INMB] Investment Guide: What You Need to Know - Knox Daily

Sep 30, 2024

Sep 30, 2024

INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease - The Manila Times

Sep 30, 2024

Sep 30, 2024

INmune Bio: NK Cell Therapy INKmune For mCRPC Is Another Shot On Goal (NASDAQ:INMB) - Seeking Alpha

Sep 30, 2024

Sep 28, 2024

CVI Holdings LLC Purchases New Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

Sep 28, 2024

Sep 28, 2024

CVI Holdings LLC Takes $5.26 Million Position in INmune Bio, Inc. (NASDAQ:INMB) - MarketBeat

Sep 28, 2024

Sep 27, 2024

Raymond James Initiates Coverage of INmune Bio (INMB) with Outperform Recommendation - MSN

Sep 27, 2024

Sep 27, 2024

Achieve, INmune, Lenz stocks win bullish view from RayJay - Seeking Alpha

Sep 27, 2024

Sep 27, 2024

INmune Bio (NASDAQ:INMB) Coverage Initiated by Analysts at Raymond James - Defense World

Sep 27, 2024

Sep 26, 2024

INmune Bio reports progress in prostate cancer trial By Investing.com - Investing.com Australia

Sep 26, 2024

Sep 26, 2024

INmune Bio reports progress in prostate cancer trial - Investing.com

Sep 26, 2024

Sep 26, 2024

INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort - The Manila Times

Sep 26, 2024